Financial - Capital Markets
Compare Stocks
5 / 10Stock Comparison
DFIN vs WLYB vs TRMK vs WK vs DSGX
Revenue, margins, valuation, and 5-year total return — side by side.
Publishing
Banks - Regional
Software - Application
Software - Application
DFIN vs WLYB vs TRMK vs WK vs DSGX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Financial - Capital Markets | Publishing | Banks - Regional | Software - Application | Software - Application |
| Market Cap | $1.11B | $2.30B | $2.64B | $2.93B | $6.31B |
| Revenue (TTM) | $767M | $1.67B | $1.12B | $926M | $731M |
| Net Income (TTM) | $35M | $154M | $224M | $14M | $164M |
| Gross Margin | 63.4% | 72.5% | 71.0% | 79.4% | 71.4% |
| Operating Margin | 19.8% | 15.3% | 25.5% | -0.3% | 30.4% |
| Forward P/E | 9.4x | 10.0x | 11.5x | 19.3x | 39.3x |
| Total Debt | $182M | $899M | $1.12B | $808M | $8M |
| Cash & Equiv. | $25M | $86M | $668M | $339M | $354M |
DFIN vs WLYB vs TRMK vs WK vs DSGX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Donnelley Financial… (DFIN) | 100 | 542.8 | +442.8% |
| John Wiley & Sons, … (WLYB) | 100 | 96.7 | -3.3% |
| Trustmark Corporati… (TRMK) | 100 | 188.7 | +88.7% |
| Workiva Inc. (WK) | 100 | 117.3 | +17.3% |
| The Descartes Syste… (DSGX) | 100 | 154.2 | +54.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DFIN vs WLYB vs TRMK vs WK vs DSGX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DFIN ranks third and is worth considering specifically for value.
- Lower P/E (9.4x vs 39.3x)
WLYB is the clearest fit if your priority is dividends.
- 3.3% yield, vs TRMK's 2.2%, (3 stocks pay no dividend)
TRMK has the current edge in this matchup, primarily because of its strength in valuation efficiency.
- PEG 1.42 vs DSGX's 1.53
- 34.8% NII/revenue growth vs WLYB's -10.4%
- +32.5% vs DSGX's -31.7%
WK is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 3 yrs, beta 0.25
- Rev growth 19.7%, EPS growth 52.5%, 3Y rev CAGR 18.0%
- Beta 0.25, current ratio 1.57x
- Beta 0.25 vs DFIN's 1.14
DSGX is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 295.4% 10Y total return vs TRMK's 127.7%
- Lower volatility, beta 0.71, Low D/E 0.5%, current ratio 2.16x
- 22.5% margin vs WK's 1.5%
- 9.2% ROA vs WK's 1.0%, ROIC 14.9% vs -7.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 34.8% NII/revenue growth vs WLYB's -10.4% | |
| Value | Lower P/E (9.4x vs 39.3x) | |
| Quality / Margins | 22.5% margin vs WK's 1.5% | |
| Stability / Safety | Beta 0.25 vs DFIN's 1.14 | |
| Dividends | 3.3% yield, vs TRMK's 2.2%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +32.5% vs DSGX's -31.7% | |
| Efficiency (ROA) | 9.2% ROA vs WK's 1.0%, ROIC 14.9% vs -7.0% |
DFIN vs WLYB vs TRMK vs WK vs DSGX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
DFIN vs WLYB vs TRMK vs WK vs DSGX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
DSGX leads in 2 of 6 categories
DFIN leads 1 • TRMK leads 1 • WLYB leads 0 • WK leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
DSGX leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WLYB is the larger business by revenue, generating $1.7B annually — 2.3x DSGX's $731M. DSGX is the more profitable business, keeping 22.5% of every revenue dollar as net income compared to WK's 1.5%. On growth, WK holds the edge at +19.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $767M | $1.7B | $1.1B | $926M | $731M |
| EBITDAEarnings before interest/tax | $217M | $402M | $323M | $6M | $310M |
| Net IncomeAfter-tax profit | $35M | $154M | $224M | $14M | $164M |
| Free Cash FlowCash after capex | $140M | $190M | $230M | $146M | $261M |
| Gross MarginGross profit ÷ Revenue | +63.4% | +72.5% | +71.0% | +79.4% | +71.4% |
| Operating MarginEBIT ÷ Revenue | +19.8% | +15.3% | +25.5% | -0.3% | +30.4% |
| Net MarginNet income ÷ Revenue | +4.2% | +9.2% | +20.0% | +1.5% | +22.5% |
| FCF MarginFCF ÷ Revenue | +14.1% | +11.4% | +20.7% | +15.8% | +35.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +1.3% | — | +19.9% | +17.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +21.0% | +2.3% | +5.4% | +186.8% | +23.3% |
Valuation Metrics
DFIN leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 12.1x trailing earnings, TRMK trades at a 68% valuation discount to DFIN's 38.5x P/E. Adjusting for growth (PEG ratio), DSGX offers better value at 1.50x vs TRMK's 1.50x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.1B | $2.3B | $2.6B | $2.9B | $6.3B |
| Enterprise ValueMkt cap + debt − cash | $1.3B | $3.1B | $3.1B | $3.4B | $6.0B |
| Trailing P/EPrice ÷ TTM EPS | 38.47x | 27.36x | 12.13x | -111.19x | 38.42x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.43x | 9.97x | 11.50x | 19.28x | 39.34x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.50x | — | 1.50x |
| EV / EBITDAEnterprise value multiple | 5.80x | 8.41x | 9.49x | — | 18.10x |
| Price / SalesMarket cap ÷ Revenue | 1.44x | 1.37x | 2.36x | 3.32x | 8.47x |
| Price / BookPrice ÷ Book value/share | 3.29x | 3.05x | 1.28x | — | 3.99x |
| Price / FCFMarket cap ÷ FCF | 10.25x | 19.16x | 11.39x | 21.25x | 23.71x |
Profitability & Efficiency
DSGX leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
WLYB delivers a 20.8% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $9 for DFIN. DSGX carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to WLYB's 1.20x. On the Piotroski fundamental quality scale (0–9), DFIN scores 7/9 vs WK's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +8.7% | +20.8% | +10.8% | — | +10.7% |
| ROA (TTM)Return on assets | +4.2% | +6.0% | +1.2% | +1.0% | +9.2% |
| ROICReturn on invested capital | +19.9% | +10.7% | +7.1% | -7.0% | +14.9% |
| ROCEReturn on capital employed | +24.6% | +11.9% | +3.2% | -5.6% | +15.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 7 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.48x | 1.20x | 0.53x | — | 0.01x |
| Net DebtTotal debt minus cash | $157M | $813M | $448M | $469M | -$346M |
| Cash & Equiv.Liquid assets | $25M | $86M | $668M | $339M | $354M |
| Total DebtShort + long-term debt | $182M | $899M | $1.1B | $808M | $8M |
| Interest CoverageEBIT ÷ Interest expense | 0.86x | 5.16x | 0.75x | 3.43x | 229.22x |
Total Returns (Dividends Reinvested)
TRMK leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DFIN five years ago would be worth $16,588 today (with dividends reinvested), compared to $5,785 for WK. Over the past 12 months, TRMK leads with a +32.5% total return vs DSGX's -31.7%. The 3-year compound annual growth rate (CAGR) favors TRMK at 29.8% vs WK's -16.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -3.0% | +35.4% | +15.5% | -37.0% | -13.8% |
| 1-Year ReturnPast 12 months | -15.8% | -1.6% | +32.5% | -22.9% | -31.7% |
| 3-Year ReturnCumulative with dividends | +4.1% | +25.9% | +118.5% | -40.8% | -5.1% |
| 5-Year ReturnCumulative with dividends | +65.9% | -20.1% | +47.6% | -42.1% | +19.7% |
| 10-Year ReturnCumulative with dividends | +90.3% | +10.2% | +127.7% | +337.0% | +295.4% |
| CAGR (3Y)Annualised 3-year return | +1.4% | +8.0% | +29.8% | -16.0% | -1.7% |
Risk & Volatility
Evenly matched — WLYB and TRMK each lead in 1 of 2 comparable metrics.
Risk & Volatility
WLYB is the less volatile stock with a -0.08 beta — it tends to amplify market swings less than DFIN's 1.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TRMK currently trades 97.6% from its 52-week high vs WK's 53.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.14x | -0.08x | 0.94x | 0.25x | 0.71x |
| 52-Week HighHighest price in past year | $66.25 | $45.41 | $45.99 | $97.10 | $117.35 |
| 52-Week LowLowest price in past year | $37.07 | $29.16 | $33.39 | $49.44 | $62.56 |
| % of 52W HighCurrent price vs 52-week peak | +66.8% | +92.2% | +97.6% | +53.8% | +62.5% |
| RSI (14)Momentum oscillator 0–100 | 28.8 | 58.5 | 56.0 | 36.4 | 47.7 |
| Avg Volume (50D)Average daily shares traded | 245K | 666 | 392K | 903K | 583K |
Analyst Outlook
Evenly matched — WLYB and WK each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DFIN as "Buy", WLYB as "Hold", TRMK as "Hold", WK as "Buy", DSGX as "Buy". Consensus price targets imply 79.9% upside for WK (target: $94) vs 1.4% for TRMK (target: $46). For income investors, WLYB offers the higher dividend yield at 3.32% vs TRMK's 2.15%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $66.00 | — | $45.50 | $94.00 | $103.50 |
| # AnalystsCovering analysts | 10 | 3 | 9 | 18 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | +3.3% | +2.2% | — | — |
| Dividend StreakConsecutive years of raises | — | 0 | 1 | 3 | — |
| Dividend / ShareAnnual DPS | — | $1.39 | $0.97 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +16.7% | +2.6% | +3.0% | +2.4% | +0.0% |
DSGX leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DFIN leads in 1 (Valuation Metrics). 2 tied.
DFIN vs WLYB vs TRMK vs WK vs DSGX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DFIN or WLYB or TRMK or WK or DSGX a better buy right now?
For growth investors, Trustmark Corporation (TRMK) is the stronger pick with 34.
8% revenue growth year-over-year, versus -10. 4% for John Wiley & Sons, Inc. (WLYB). Trustmark Corporation (TRMK) offers the better valuation at 12. 1x trailing P/E (11. 5x forward), making it the more compelling value choice. Analysts rate Donnelley Financial Solutions, Inc. (DFIN) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DFIN or WLYB or TRMK or WK or DSGX?
On trailing P/E, Trustmark Corporation (TRMK) is the cheapest at 12.
1x versus Donnelley Financial Solutions, Inc. at 38. 5x. On forward P/E, Donnelley Financial Solutions, Inc. is actually cheaper at 9. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Trustmark Corporation wins at 1. 42x versus The Descartes Systems Group Inc. 's 1. 53x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — DFIN or WLYB or TRMK or WK or DSGX?
Over the past 5 years, Donnelley Financial Solutions, Inc.
(DFIN) delivered a total return of +65. 9%, compared to -42. 1% for Workiva Inc. (WK). Over 10 years, the gap is even starker: WK returned +337. 0% versus WLYB's +10. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DFIN or WLYB or TRMK or WK or DSGX?
By beta (market sensitivity over 5 years), John Wiley & Sons, Inc.
(WLYB) is the lower-risk stock at -0. 08β versus Donnelley Financial Solutions, Inc. 's 1. 14β — meaning DFIN is approximately -1443% more volatile than WLYB relative to the S&P 500. On balance sheet safety, The Descartes Systems Group Inc. (DSGX) carries a lower debt/equity ratio of 1% versus 120% for John Wiley & Sons, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DFIN or WLYB or TRMK or WK or DSGX?
By revenue growth (latest reported year), Trustmark Corporation (TRMK) is pulling ahead at 34.
8% versus -10. 4% for John Wiley & Sons, Inc. (WLYB). On earnings-per-share growth, the picture is similar: John Wiley & Sons, Inc. grew EPS 141. 9% year-over-year, compared to -62. 4% for Donnelley Financial Solutions, Inc.. Over a 3-year CAGR, WK leads at 18. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DFIN or WLYB or TRMK or WK or DSGX?
The Descartes Systems Group Inc.
(DSGX) is the more profitable company, earning 22. 5% net margin versus -3. 0% for Workiva Inc. — meaning it keeps 22. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DSGX leads at 32. 3% versus -4. 8% for WK. At the gross margin level — before operating expenses — WK leads at 78. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DFIN or WLYB or TRMK or WK or DSGX more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Trustmark Corporation (TRMK) is the more undervalued stock at a PEG of 1. 42x versus The Descartes Systems Group Inc. 's 1. 53x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Donnelley Financial Solutions, Inc. (DFIN) trades at 9. 4x forward P/E versus 39. 3x for The Descartes Systems Group Inc. — 29. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WK: 79. 9% to $94. 00.
08Which pays a better dividend — DFIN or WLYB or TRMK or WK or DSGX?
In this comparison, WLYB (3.
3% yield), TRMK (2. 2% yield) pay a dividend. DFIN, WK, DSGX do not pay a meaningful dividend and should not be held primarily for income.
09Is DFIN or WLYB or TRMK or WK or DSGX better for a retirement portfolio?
For long-horizon retirement investors, John Wiley & Sons, Inc.
(WLYB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 08), 3. 3% yield). Both have compounded well over 10 years (WLYB: +10. 2%, DFIN: +90. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DFIN and WLYB and TRMK and WK and DSGX?
These companies operate in different sectors (DFIN (Financial Services) and WLYB (Communication Services) and TRMK (Financial Services) and WK (Technology) and DSGX (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: DFIN is a small-cap quality compounder stock; WLYB is a small-cap income-oriented stock; TRMK is a small-cap high-growth stock; WK is a small-cap high-growth stock; DSGX is a small-cap quality compounder stock. WLYB, TRMK pay a dividend while DFIN, WK, DSGX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.